Epidemiology of Gastrointestinal Neuroendocrine Tumors in a U.S. Commercially Insured Population
Authors:
- Michael S. BroderMBMichael S. Broder
- Beilei CaiBCBeilei Cai
- Eunice ChangECEunice Chang
- Maureen P. NearyMNMaureen P. Neary
- 1 October 2017
- journal article
- Published by Elsevier in Endocrine Practice
- Vol. 23 (10) , 1210-1216
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United StatesJAMA Oncology, 2017
- Exploring the rising incidence of neuroendocrine tumors: A population‐based analysis of epidemiology, metastatic presentation, and outcomesCancer, 2014
- Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysisJournal of Gastroenterology, 2014
- Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literatureEndocrine-Related Cancer, 2013
- Laparoendoscopic single-site versus conventional laparoscopic total extraperitoneal hernia repair: a prospective randomized clinical trialSurgical Endoscopy, 2013
- Incidence and survival of neuroendocrine tumours in the Netherlands according to histological grade: Experience of two decades of cancer registryEuropean Journal of Cancer, 2013
- Trends of Incidence and Survival of Gastrointestinal Neuroendocrine Tumors in the United States: A Seer AnalysisJournal of Cancer, 2012
- The NANETS Consensus Guideline for the Diagnosis and Management of Neuroendocrine TumorsPancreas, 2010
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United StatesJournal of Clinical Oncology, 2008
- Gastroenteropancreatic neuroendocrine tumoursThe Lancet Oncology, 2008